25 XP   0   0   10

biOasis Technologies Inc
Buy, Hold or Sell?

Let's analyse Bioasis together

PenkeI guess you are interested in biOasis Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of biOasis Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about biOasis Technologies Inc

I send you an email if I find something interesting about biOasis Technologies Inc.

Quick analysis of Bioasis (30 sec.)










What can you expect buying and holding a share of Bioasis? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.02
Expected worth in 1 year
C$-0.14
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
C$-0.12
Return On Investment
-1,170.9%

For what price can you sell your share?

Current Price per Share
C$0.01
Expected price per share
C$0.01 - C$0.01
How sure are you?
50%

1. Valuation of Bioasis (5 min.)




Live pricePrice per Share (EOD)

C$0.01

Intrinsic Value Per Share

C$-0.44 - C$-0.26

Total Value Per Share

C$-0.47 - C$-0.28

2. Growth of Bioasis (5 min.)




Is Bioasis growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.3m-$758.4k-$640.4k-45.8%

How much money is Bioasis making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$1.2m-$934.6k-43.3%
Net Profit Margin-7,846.5%-325.9%--

How much money comes from the company's main activities?

3. Financial Health of Bioasis (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#883 / 1010

Most Revenue
#676 / 1010

Most Profit
#308 / 1010

Most Efficient
#933 / 1010

What can you expect buying and holding a share of Bioasis? (5 min.)

Welcome investor! Bioasis's management wants to use your money to grow the business. In return you get a share of Bioasis.

What can you expect buying and holding a share of Bioasis?

First you should know what it really means to hold a share of Bioasis. And how you can make/lose money.

Speculation

The Price per Share of Bioasis is C$0.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioasis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioasis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.02. Based on the TTM, the Book Value Change Per Share is C$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioasis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.03-272.0%-0.03-272.0%-0.02-154.3%-0.03-277.4%-0.03-276.7%
Usd Book Value Change Per Share-0.02-213.6%-0.02-213.6%0.0043.8%0.00-41.9%0.00-19.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-213.6%-0.02-213.6%0.0043.8%0.00-41.9%0.00-19.6%
Usd Price Per Share0.20-0.20-0.22-0.28-0.51-
Price to Earnings Ratio-7.24--7.24-18.22-1.99--11.99-
Price-to-Total Gains Ratio-9.22--9.22-0.23-132.73-10.56-
Price to Book Ratio-11.18--11.18-31.43-20.89-49.81-
Price-to-Total Gains Ratio-9.22--9.22-0.23-132.73-10.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.007296
Number of shares137061
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (137061 shares)-2,927.13-574.40
Gains per Year (137061 shares)-11,708.52-2,297.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-11709-117190-2298-2308
20-23417-234280-4595-4606
30-35126-351370-6893-6904
40-46834-468460-9190-9202
50-58543-585550-11488-11500
60-70251-702640-13786-13798
70-81960-819730-16083-16096
80-93668-936820-18381-18394
90-105377-1053910-20678-20692
100-117085-1171000-22976-22990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.08.00.011.1%1.08.00.011.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.06.00.033.3%3.06.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.06.00.033.3%3.06.00.033.3%

Fundamentals of Bioasis

About biOasis Technologies Inc

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane's OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis' xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Fundamental data was last updated by Penke on 2024-04-13 08:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of biOasis Technologies Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioasis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • A Net Profit Margin of -7,846.5% means that $-78.46 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of biOasis Technologies Inc:

  • The MRQ is -7,846.5%. The company is making a huge loss. -2
  • The TTM is -7,846.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,846.5%TTM-7,846.5%0.0%
TTM-7,846.5%YOY-325.9%-7,520.6%
TTM-7,846.5%5Y-1,928.5%-5,918.0%
5Y-1,928.5%10Y-1,213.6%-714.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,846.5%-200.1%-7,646.4%
TTM-7,846.5%-216.8%-7,629.7%
YOY-325.9%-288.3%-37.6%
5Y-1,928.5%-449.1%-1,479.4%
10Y-1,213.6%-605.5%-608.1%
1.1.2. Return on Assets

Shows how efficient Bioasis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • -130.6% Return on Assets means that Bioasis generated $-1.31 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of biOasis Technologies Inc:

  • The MRQ is -130.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -130.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-130.6%TTM-130.6%0.0%
TTM-130.6%YOY-204.7%+74.1%
TTM-130.6%5Y-234.7%+104.1%
5Y-234.7%10Y-203.4%-31.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-130.6%-13.3%-117.3%
TTM-130.6%-12.8%-117.8%
YOY-204.7%-11.7%-193.0%
5Y-234.7%-13.9%-220.8%
10Y-203.4%-15.7%-187.7%
1.1.3. Return on Equity

Shows how efficient Bioasis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • 0.0% Return on Equity means Bioasis generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of biOasis Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY85.8%-85.8%
TTM-5Y-210.2%+210.2%
5Y-210.2%10Y-257.4%+47.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY85.8%-15.1%+100.9%
5Y-210.2%-19.3%-190.9%
10Y-257.4%-20.2%-237.2%

1.2. Operating Efficiency of biOasis Technologies Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioasis is operating .

  • Measures how much profit Bioasis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • An Operating Margin of -9,534.2% means the company generated $-95.34  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of biOasis Technologies Inc:

  • The MRQ is -9,534.2%. The company is operating very inefficient. -2
  • The TTM is -9,534.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9,534.2%TTM-9,534.2%0.0%
TTM-9,534.2%YOY-374.8%-9,159.4%
TTM-9,534.2%5Y-2,304.0%-7,230.2%
5Y-2,304.0%10Y-1,421.9%-882.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9,534.2%-296.2%-9,238.0%
TTM-9,534.2%-232.5%-9,301.7%
YOY-374.8%-298.2%-76.6%
5Y-2,304.0%-492.1%-1,811.9%
10Y-1,421.9%-632.4%-789.5%
1.2.2. Operating Ratio

Measures how efficient Bioasis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 96.34 means that the operating costs are $96.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of biOasis Technologies Inc:

  • The MRQ is 96.342. The company is inefficient in keeping operating costs low. -1
  • The TTM is 96.342. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ96.342TTM96.3420.000
TTM96.342YOY4.761+91.581
TTM96.3425Y24.205+72.137
5Y24.20510Y15.309+8.897
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ96.3423.231+93.111
TTM96.3423.310+93.032
YOY4.7613.890+0.871
5Y24.2055.739+18.466
10Y15.3097.876+7.433

1.3. Liquidity of biOasis Technologies Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioasis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.70 means the company has $0.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.705. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.705. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.705TTM0.7050.000
TTM0.705YOY0.937-0.232
TTM0.7055Y0.936-0.231
5Y0.93610Y3.221-2.285
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7053.890-3.185
TTM0.7054.173-3.468
YOY0.9375.344-4.407
5Y0.9366.126-5.190
10Y3.2216.448-3.227
1.3.2. Quick Ratio

Measures if Bioasis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • A Quick Ratio of 0.03 means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.033. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.033. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.033TTM0.0330.000
TTM0.033YOY0.011+0.022
TTM0.0335Y0.021+0.012
5Y0.02110Y0.943-0.922
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0333.514-3.481
TTM0.0333.998-3.965
YOY0.0115.380-5.369
5Y0.0216.105-6.084
10Y0.9436.404-5.461

1.4. Solvency of biOasis Technologies Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioasis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioasis to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.85 means that Bioasis assets are financed with 184.6% credit (debt) and the remaining percentage (100% - 184.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of biOasis Technologies Inc:

  • The MRQ is 1.846. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.846. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.846TTM1.8460.000
TTM1.846YOY2.258-0.412
TTM1.8465Y1.664+0.182
5Y1.66410Y1.040+0.624
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8460.339+1.507
TTM1.8460.336+1.510
YOY2.2580.271+1.987
5Y1.6640.366+1.298
10Y1.0400.389+0.651
1.4.2. Debt to Equity Ratio

Measures if Bioasis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioasis to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of biOasis Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.523-3.523
TTM-5Y1.772-1.772
5Y1.77210Y1.261+0.511
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.402-0.402
YOY3.5230.335+3.188
5Y1.7720.426+1.346
10Y1.2610.461+0.800

2. Market Valuation of biOasis Technologies Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bioasis generates.

  • Above 15 is considered overpriced but always compare Bioasis to the Biotechnology industry mean.
  • A PE ratio of -7.24 means the investor is paying $-7.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of biOasis Technologies Inc:

  • The EOD is -0.268. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.244. Based on the earnings, the company is expensive. -2
  • The TTM is -7.244. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.268MRQ-7.244+6.975
MRQ-7.244TTM-7.2440.000
TTM-7.244YOY18.216-25.459
TTM-7.2445Y1.986-9.230
5Y1.98610Y-11.988+13.974
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.268-2.264+1.996
MRQ-7.244-2.629-4.615
TTM-7.244-2.680-4.564
YOY18.216-4.145+22.361
5Y1.986-6.257+8.243
10Y-11.988-6.254-5.734
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of biOasis Technologies Inc:

  • The EOD is -0.218. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.898. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.898. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.218MRQ-5.898+5.679
MRQ-5.898TTM-5.8980.000
TTM-5.898YOY5.301-11.199
TTM-5.8985Y-3.819-2.079
5Y-3.81910Y-23.779+19.959
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.218-2.973+2.755
MRQ-5.898-3.333-2.565
TTM-5.898-3.553-2.345
YOY5.301-5.605+10.906
5Y-3.819-8.376+4.557
10Y-23.779-8.865-14.914
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioasis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -11.18 means the investor is paying $-11.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of biOasis Technologies Inc:

  • The EOD is -0.414. Based on the equity, the company is expensive. -2
  • The MRQ is -11.183. Based on the equity, the company is expensive. -2
  • The TTM is -11.183. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.414MRQ-11.183+10.769
MRQ-11.183TTM-11.1830.000
TTM-11.183YOY31.432-42.615
TTM-11.1835Y20.891-32.073
5Y20.89110Y49.806-28.916
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4141.896-2.310
MRQ-11.1832.115-13.298
TTM-11.1832.093-13.276
YOY31.4322.884+28.548
5Y20.8913.542+17.349
10Y49.8063.916+45.890
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of biOasis Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.029-0.0290%0.006-587%-0.006-80%-0.003-91%
Book Value Per Share---0.024-0.0240%-0.013-46%-0.010-57%0.003-828%
Current Ratio--0.7050.7050%0.937-25%0.936-25%3.221-78%
Debt To Asset Ratio--1.8461.8460%2.258-18%1.664+11%1.040+78%
Debt To Equity Ratio----0%3.523-100%1.772-100%1.261-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.037-0.0370%-0.021-43%-0.038+2%-0.038+2%
Free Cash Flow Per Share---0.046-0.0460%-0.010-79%-0.031-33%-0.028-39%
Free Cash Flow To Equity Per Share---0.013-0.0130%0.008-256%0.002-818%-0.003-78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.261--------
Intrinsic Value_10Y_min---0.444--------
Intrinsic Value_1Y_max---0.023--------
Intrinsic Value_1Y_min---0.035--------
Intrinsic Value_3Y_max---0.071--------
Intrinsic Value_3Y_min---0.113--------
Intrinsic Value_5Y_max---0.122--------
Intrinsic Value_5Y_min---0.201--------
Market Cap794140.000-2600%21441780.00021441780.0000%23427130.000-8%30494976.000-30%55678037.778-61%
Net Profit Margin---78.465-78.4650%-3.259-96%-19.285-75%-12.136-85%
Operating Margin---95.342-95.3420%-3.748-96%-23.040-76%-14.219-85%
Operating Ratio--96.34296.3420%4.761+1924%24.205+298%15.309+529%
Pb Ratio-0.414+96%-11.183-11.1830%31.432-136%20.891-154%49.806-122%
Pe Ratio-0.268+96%-7.244-7.2440%18.216-140%1.986-465%-11.988+65%
Price Per Share0.010-2600%0.2700.2700%0.295-8%0.384-30%0.701-61%
Price To Free Cash Flow Ratio-0.218+96%-5.898-5.8980%5.301-211%-3.819-35%-23.779+303%
Price To Total Gains Ratio-0.342+96%-9.224-9.2240%0.232-4079%132.733-107%10.559-187%
Quick Ratio--0.0330.0330%0.011+206%0.021+56%0.943-97%
Return On Assets---1.306-1.3060%-2.047+57%-2.347+80%-2.034+56%
Return On Equity----0%0.858-100%-2.1020%-2.5740%
Total Gains Per Share---0.029-0.0290%0.006-587%-0.006-80%-0.003-91%
Usd Book Value---1398907.315-1398907.3150%-758449.114-46%-599578.568-57%192108.787-828%
Usd Book Value Change Per Share---0.021-0.0210%0.004-587%-0.004-80%-0.002-91%
Usd Book Value Per Share---0.018-0.0180%-0.010-46%-0.008-57%0.002-828%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.027-0.0270%-0.015-43%-0.028+2%-0.028+2%
Usd Free Cash Flow---2652464.448-2652464.4480%-557113.805-79%-1776615.252-33%-1608090.445-39%
Usd Free Cash Flow Per Share---0.033-0.0330%-0.007-79%-0.022-33%-0.020-39%
Usd Free Cash Flow To Equity Per Share---0.009-0.0090%0.006-256%0.001-818%-0.002-78%
Usd Market Cap579404.544-2600%15643922.68815643922.6880%17092434.048-8%22249134.490-30%40622696.363-61%
Usd Price Per Share0.007-2600%0.1970.1970%0.215-8%0.280-30%0.512-61%
Usd Profit---2159683.123-2159683.1230%-1225002.048-43%-2203312.328+2%-2197680.934+2%
Usd Revenue--27524.16027524.1600%1708910.342-98%982641.623-97%617420.109-96%
Usd Total Gains Per Share---0.021-0.0210%0.004-587%-0.004-80%-0.002-91%
 EOD+2 -6MRQTTM+0 -0YOY+8 -255Y+10 -2210Y+7 -25

3.2. Fundamental Score

Let's check the fundamental score of biOasis Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.268
Price to Book Ratio (EOD)Between0-1-0.414
Net Profit Margin (MRQ)Greater than0-78.465
Operating Margin (MRQ)Greater than0-95.342
Quick Ratio (MRQ)Greater than10.033
Current Ratio (MRQ)Greater than10.705
Debt to Asset Ratio (MRQ)Less than11.846
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.306
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of biOasis Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.010
OpenGreater thanClose0.010
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-02-28. Currency in CAD. All numbers in thousands.

Summary
Total Assets2,266
Total Liabilities4,183
Total Stockholder Equity-1,917
 As reported
Total Liabilities 4,183
Total Stockholder Equity+ -1,917
Total Assets = 2,266

Assets

Total Assets2,266
Total Current Assets2,107
Long-term Assets159
Total Current Assets
Cash And Cash Equivalents 1,731
Net Receivables 98
Total Current Assets  (as reported)2,107
Total Current Assets  (calculated)1,828
+/- 278
Long-term Assets
Property Plant Equipment 0
Intangible Assets 159
Long-term Assets  (as reported)159
Long-term Assets  (calculated)159
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,989
Long-term Liabilities1,194
Total Stockholder Equity-1,917
Total Current Liabilities
Short Long Term Debt 1,500
Accounts payable 1,489
Total Current Liabilities  (as reported)2,989
Total Current Liabilities  (calculated)2,989
+/-0
Long-term Liabilities
Long term Debt 402
Other Liabilities 792
Long-term Liabilities  (as reported)1,194
Long-term Liabilities  (calculated)1,194
+/-0
Total Stockholder Equity
Common Stock27,454
Retained Earnings -40,654
Other Stockholders Equity 185
Total Stockholder Equity (as reported)-1,917
Total Stockholder Equity (calculated)-13,016
+/- 11,098
Other
Capital Stock27,454
Common Stock Shares Outstanding 72,914
Net Debt 171
Net Invested Capital -16
Net Tangible Assets -2,076
Net Working Capital -883



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-02-282021-02-282020-02-292019-02-282018-02-282017-02-282016-02-292015-02-282014-02-28
> Total Assets 
2,579
2,212
2,153
1,111
1,222
1,743
942
3,276
2,266
2,2663,2769421,7431,2221,1112,1532,2122,579
   > Total Current Assets 
2,047
1,730
1,723
731
793
1,382
652
3,059
2,107
2,1073,0596521,3827937311,7231,7302,047
       Cash And Cash Equivalents 
1,092
1,339
773
554
678
1,360
576
2,737
1,731
1,7312,7375761,3606785547731,3391,092
       Short-term Investments 
750
300
850
0
0
0
0
0
0
000000850300750
       Net Receivables 
137
14
30
58
34
10
13
30
98
9830131034583014137
       Other Current Assets 
0
62
52
90
0
0
0
0
0
000009052620
   > Long-term Assets 
0
0
0
380
428
361
290
217
159
159217290361428380000
       Property Plant Equipment 
8
7
5
3
42
33
21
5
0
052133423578
       Intangible Assets 
524
474
425
376
387
328
269
213
159
159213269328387376425474524
> Total Liabilities 
188
207
434
748
788
2,290
3,428
2,869
4,183
4,1832,8693,4282,290788748434207188
   > Total Current Liabilities 
186
207
434
748
788
1,263
2,477
1,899
2,989
2,9891,8992,4771,263788748434207186
       Short Long Term Debt 
0
0
0
0
0
0
486
56
1,500
1,50056486000000
       Accounts payable 
185
205
300
557
788
999
1,991
1,843
1,489
1,4891,8431,991999788557300205185
       Other Current Liabilities 
1
1
112
174
0
264
0
0
0
000264017411211
   > Long-term Liabilities 
0
0
0
0
0
1,027
951
970
1,194
1,1949709511,02700000
> Total Stockholder Equity
2,391
2,005
1,719
363
434
-547
-2,486
407
-1,917
-1,917407-2,486-5474343631,7192,0052,391
   Common Stock
14,660
16,744
18,363
18,649
22,791
24,199
25,418
27,258
27,454
27,45427,25825,41824,19922,79118,64918,36316,74414,660
   Retained Earnings -40,654-37,694-38,392-34,336-30,862-25,555-22,564-19,991-17,155
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
0
31
25
17
186
185
1851861725310000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2022-02-28)

Gross Profit (+$)
totalRevenue38
Cost of Revenue-0
Gross Profit038
 
Operating Income (+$)
Gross Profit0
Operating Expense-3,635
Operating Income-3,597-3,635
 
Operating Expense (+$)
Research Development1,226
Selling General Administrative2,408
Selling And Marketing Expenses0
Operating Expense3,6353,635
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-654
Net Interest Income-654
 
Pretax Income (+$)
Operating Income-3,597
Net Interest Income-654
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,960-4,888
EBIT - interestExpense = -3,597
-2,960
-2,960
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-3,597-2,960
Earnings Before Interest and Taxes (EBITDA)-3,542
 
After tax Income (+$)
Income Before Tax-2,960
Tax Provision-0
Net Income From Continuing Ops-2,960-2,960
Net Income-2,960
Net Income Applicable To Common Shares-2,960
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,291654
 

Technical Analysis of Bioasis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioasis. The general trend of Bioasis is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioasis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of biOasis Technologies Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.01 < 0.01 < 0.01.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
biOasis Technologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of biOasis Technologies Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

biOasis Technologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of biOasis Technologies Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioasis price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bioasis. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bioasis price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
biOasis Technologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartbiOasis Technologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of biOasis Technologies Inc. The current adx is 29.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
biOasis Technologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of biOasis Technologies Inc. The current sar is 0.01014664.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
biOasis Technologies Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of biOasis Technologies Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
biOasis Technologies Inc Daily Relative Strength Index (RSI) ChartbiOasis Technologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of biOasis Technologies Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioasis price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
biOasis Technologies Inc Daily Stochastic Oscillator ChartbiOasis Technologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of biOasis Technologies Inc. The current cci is -66.66666667.

biOasis Technologies Inc Daily Commodity Channel Index (CCI) ChartbiOasis Technologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of biOasis Technologies Inc. The current cmo is 0.

biOasis Technologies Inc Daily Chande Momentum Oscillator (CMO) ChartbiOasis Technologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of biOasis Technologies Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
biOasis Technologies Inc Daily Williams %R ChartbiOasis Technologies Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of biOasis Technologies Inc.

biOasis Technologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of biOasis Technologies Inc. The current atr is 0.

biOasis Technologies Inc Daily Average True Range (ATR) ChartbiOasis Technologies Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of biOasis Technologies Inc. The current obv is -7,637,300.

biOasis Technologies Inc Daily On-Balance Volume (OBV) ChartbiOasis Technologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of biOasis Technologies Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
biOasis Technologies Inc Daily Money Flow Index (MFI) ChartbiOasis Technologies Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for biOasis Technologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

biOasis Technologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of biOasis Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.010
OpenGreater thanClose0.010
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bioasis with someone you think should read this too:
  • Are you bullish or bearish on Bioasis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioasis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about biOasis Technologies Inc

I send you an email if I find something interesting about biOasis Technologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about biOasis Technologies Inc.

Receive notifications about biOasis Technologies Inc in your mailbox!